UniProt ID | SNX3_HUMAN | |
---|---|---|
UniProt AC | O60493 | |
Protein Name | Sorting nexin-3 | |
Gene Name | SNX3 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 162 | |
Subcellular Localization | Early endosome . Cytoplasmic vesicle, phagosome . Colocalizes to clathrin-coated endosomal vesicles morphologically distinct from retromer-decorated non-branched endosomal tubule structures (PubMed:21725319) Colocalizes with EEA1 on nascent phagosome | |
Protein Description | Phosphoinositide-binding protein required for multivesicular body formation. Specifically binds phosphatidylinositol 3-phosphate (PtdIns(P3)). Also can bind phosphatidylinositol 4-phosphate (PtdIns(P4)), phosphatidylinositol 5-phosphate (PtdIns(P5)) and phosphatidylinositol 3,5-biphosphate (PtdIns(3,5)P2) (By similarity). Plays a role in protein transport between cellular compartments. Together with RAB7A facilitates endosome membrane association of the retromer cargo-selective subcomplex (CSC/VPS). May in part act as component of the SNX3-retromer complex which mediates the retrograde endosome-to-TGN transport of WLS distinct from the SNX-BAR retromer pathway. [PubMed: 21725319] | |
Protein Sequence | MAETVADTRRLITKPQNLNDAYGPPSNFLEIDVSNPQTVGVGRGRFTTYEIRVKTNLPIFKLKESTVRRRYSDFEWLRSELERESKVVVPPLPGKAFLRQLPFRGDDGIFDDNFIEERKQGLEQFINKVAGHPLAQNERCLHMFLQDEIIDKSYTPSKIRHA | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MAETVADTR ------CCCCHHHHH | 22.59 | 25944712 | |
8 | Phosphorylation | MAETVADTRRLITKP CCCCHHHHHHHCCCC | 14.14 | 20068231 | |
13 | Phosphorylation | ADTRRLITKPQNLND HHHHHHCCCCCCCCC | 41.06 | 26552605 | |
14 | Ubiquitination | DTRRLITKPQNLNDA HHHHHCCCCCCCCCC | 37.30 | - | |
22 | Phosphorylation | PQNLNDAYGPPSNFL CCCCCCCCCCCCCCE | 32.78 | 29978859 | |
26 | Phosphorylation | NDAYGPPSNFLEIDV CCCCCCCCCCEEEEC | 43.26 | 25394399 | |
39 | Ubiquitination | DVSNPQTVGVGRGRF ECCCCCEEEECCCCC | 5.01 | 21890473 | |
41 | Ubiquitination | SNPQTVGVGRGRFTT CCCCEEEECCCCCEE | 4.03 | 22817900 | |
43 | Methylation | PQTVGVGRGRFTTYE CCEEEECCCCCEEEE | 30.61 | 24129315 | |
43 | Dimethylation | PQTVGVGRGRFTTYE CCEEEECCCCCEEEE | 30.61 | - | |
45 | Dimethylation | TVGVGRGRFTTYEIR EEEECCCCCEEEEEE | 25.11 | - | |
45 | Methylation | TVGVGRGRFTTYEIR EEEECCCCCEEEEEE | 25.11 | 12018303 | |
47 | Phosphorylation | GVGRGRFTTYEIRVK EECCCCCEEEEEEEE | 27.40 | 20860994 | |
48 | Phosphorylation | VGRGRFTTYEIRVKT ECCCCCEEEEEEEEC | 19.22 | 20860994 | |
49 | Phosphorylation | GRGRFTTYEIRVKTN CCCCCEEEEEEEECC | 13.29 | 20860994 | |
50 | Phosphorylation | RGRFTTYEIRVKTNL CCCCEEEEEEEECCC | 23.40 | 32645325 | |
54 | Ubiquitination | TTYEIRVKTNLPIFK EEEEEEEECCCCEEE | 23.11 | 33845483 | |
55 | Phosphorylation | TYEIRVKTNLPIFKL EEEEEEECCCCEEEC | 38.85 | 22817900 | |
61 (in isoform 3) | Ubiquitination | - | 60.41 | 21906983 | |
61 (in isoform 1) | Ubiquitination | - | 60.41 | 21890473 | |
61 | Acetylation | KTNLPIFKLKESTVR ECCCCEEECCCCHHH | 60.41 | 26051181 | |
61 | Ubiquitination | KTNLPIFKLKESTVR ECCCCEEECCCCHHH | 60.41 | 27667366 | |
61 | Malonylation | KTNLPIFKLKESTVR ECCCCEEECCCCHHH | 60.41 | 32601280 | |
63 | Ubiquitination | NLPIFKLKESTVRRR CCCEEECCCCHHHHH | 50.65 | 23000965 | |
63 (in isoform 2) | Ubiquitination | - | 50.65 | 21890473 | |
64 | Ubiquitination | LPIFKLKESTVRRRY CCEEECCCCHHHHHH | 63.18 | 30230243 | |
66 | Phosphorylation | IFKLKESTVRRRYSD EEECCCCHHHHHHHC | 21.08 | - | |
71 (in isoform 3) | Phosphorylation | - | 15.69 | - | |
71 | Phosphorylation | ESTVRRRYSDFEWLR CCHHHHHHHCHHHHH | 15.69 | 23927012 | |
72 (in isoform 3) | Phosphorylation | - | 33.73 | 29116813 | |
72 | Phosphorylation | STVRRRYSDFEWLRS CHHHHHHHCHHHHHH | 33.73 | 22167270 | |
73 (in isoform 4) | Ubiquitination | - | 36.23 | 21890473 | |
73 | Ubiquitination | TVRRRYSDFEWLRSE HHHHHHHCHHHHHHH | 36.23 | 23000965 | |
79 | Phosphorylation | SDFEWLRSELERESK HCHHHHHHHHHHHCC | 44.34 | 28450419 | |
85 | Phosphorylation | RSELERESKVVVPPL HHHHHHHCCEECCCC | 36.65 | 21406692 | |
86 | Malonylation | SELERESKVVVPPLP HHHHHHCCEECCCCC | 34.00 | 32601280 | |
86 | Sumoylation | SELERESKVVVPPLP HHHHHHCCEECCCCC | 34.00 | - | |
86 | Ubiquitination | SELERESKVVVPPLP HHHHHHCCEECCCCC | 34.00 | 30230243 | |
86 | Sumoylation | SELERESKVVVPPLP HHHHHHCCEECCCCC | 34.00 | - | |
87 (in isoform 2) | Ubiquitination | - | 7.95 | 21890473 | |
87 | Ubiquitination | ELERESKVVVPPLPG HHHHHCCEECCCCCC | 7.95 | 22817900 | |
95 | Sumoylation | VVPPLPGKAFLRQLP ECCCCCCCHHHHCCC | 33.74 | - | |
95 | Ubiquitination | VVPPLPGKAFLRQLP ECCCCCCCHHHHCCC | 33.74 | 23000965 | |
95 (in isoform 1) | Ubiquitination | - | 33.74 | 21890473 | |
95 | Ubiquitination | VVPPLPGKAFLRQLP ECCCCCCCHHHHCCC | 33.74 | 21890473 | |
95 | Sumoylation | VVPPLPGKAFLRQLP ECCCCCCCHHHHCCC | 33.74 | 28112733 | |
96 | Ubiquitination | VPPLPGKAFLRQLPF CCCCCCCHHHHCCCC | 18.02 | 30230243 | |
97 (in isoform 4) | Ubiquitination | - | 7.05 | 21890473 | |
97 | Ubiquitination | PPLPGKAFLRQLPFR CCCCCCHHHHCCCCC | 7.05 | 22817900 | |
106 | Ubiquitination | RQLPFRGDDGIFDDN HCCCCCCCCCCCCCC | 46.86 | 30230243 | |
119 | Ubiquitination | DNFIEERKQGLEQFI CCHHHHHHHHHHHHH | 52.58 | 21890473 | |
119 | Sumoylation | DNFIEERKQGLEQFI CCHHHHHHHHHHHHH | 52.58 | - | |
119 (in isoform 1) | Ubiquitination | - | 52.58 | 21890473 | |
119 | Sumoylation | DNFIEERKQGLEQFI CCHHHHHHHHHHHHH | 52.58 | - | |
119 | Ubiquitination | DNFIEERKQGLEQFI CCHHHHHHHHHHHHH | 52.58 | 22817900 | |
120 | Ubiquitination | NFIEERKQGLEQFIN CHHHHHHHHHHHHHH | 68.85 | 29967540 | |
125 (in isoform 2) | Phosphorylation | - | 4.92 | - | |
126 | Ubiquitination | KQGLEQFINKVAGHP HHHHHHHHHHHCCCH | 4.95 | 22505724 | |
128 | Ubiquitination | GLEQFINKVAGHPLA HHHHHHHHHCCCHHH | 28.75 | 30230243 | |
128 | Sumoylation | GLEQFINKVAGHPLA HHHHHHHHHCCCHHH | 28.75 | - | |
130 | Ubiquitination | EQFINKVAGHPLAQN HHHHHHHCCCHHHCC | 16.52 | 29967540 | |
136 | Ubiquitination | VAGHPLAQNERCLHM HCCCHHHCCHHHHHH | 61.06 | 22505724 | |
140 | Glutathionylation | PLAQNERCLHMFLQD HHHCCHHHHHHHHCH | 2.20 | 22555962 | |
152 | Ubiquitination | LQDEIIDKSYTPSKI HCHHHHCCCCCHHHC | 34.65 | 29967540 | |
153 | Phosphorylation | QDEIIDKSYTPSKIR CHHHHCCCCCHHHCC | 30.41 | 23927012 | |
154 | Phosphorylation | DEIIDKSYTPSKIRH HHHHCCCCCHHHCCC | 28.54 | 23927012 | |
155 | Phosphorylation | EIIDKSYTPSKIRHA HHHCCCCCHHHCCCC | 28.33 | 23927012 | |
157 | Phosphorylation | IDKSYTPSKIRHA-- HCCCCCHHHCCCC-- | 32.68 | 20068231 | |
158 | Sumoylation | DKSYTPSKIRHA--- CCCCCHHHCCCC--- | 44.99 | - | |
158 | Ubiquitination | DKSYTPSKIRHA--- CCCCCHHHCCCC--- | 44.99 | 22505724 | |
158 | Sumoylation | DKSYTPSKIRHA--- CCCCCHHHCCCC--- | 44.99 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of SNX3_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of SNX3_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of SNX3_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
UBP10_HUMAN | USP10 | physical | 18632802 | |
SCNNA_HUMAN | SCNN1A | physical | 18632802 | |
VPS35_HUMAN | VPS35 | physical | 22673115 | |
SRPRB_HUMAN | SRPRB | physical | 22939629 | |
SSBP_HUMAN | SSBP1 | physical | 22939629 | |
STX7_HUMAN | STX7 | physical | 22939629 | |
ZC11A_HUMAN | ZC3H11A | physical | 22939629 | |
AR6P1_HUMAN | ARL6IP1 | physical | 25416956 | |
AK1A1_HUMAN | AKR1A1 | physical | 26344197 | |
AK1C2_HUMAN | AKR1C2 | physical | 26344197 | |
PIN1_HUMAN | PIN1 | physical | 26344197 | |
PPIL3_HUMAN | PPIL3 | physical | 26344197 | |
RBM12_HUMAN | RBM12 | physical | 26344197 | |
TAGL_HUMAN | TAGLN | physical | 26344197 | |
TAGL2_HUMAN | TAGLN2 | physical | 26344197 | |
TAGL3_HUMAN | TAGLN3 | physical | 26344197 | |
PYRG1_HUMAN | CTPS1 | physical | 26496610 | |
SSFA2_HUMAN | SSFA2 | physical | 26496610 | |
SMC1A_HUMAN | SMC1A | physical | 26496610 | |
KCAB2_HUMAN | KCNAB2 | physical | 26496610 | |
MPDZ_HUMAN | MPDZ | physical | 26496610 | |
PYRG2_HUMAN | CTPS2 | physical | 26496610 | |
ANO3_HUMAN | ANO3 | physical | 26496610 | |
RT05_HUMAN | MRPS5 | physical | 26496610 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
OMIM Disease | ||||||
601349 | Microphthalmia, syndromic, 8 (MCOPS8) | |||||
Kegg Drug | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, AND MASS SPECTROMETRY. | |
"Exploring proteomes and analyzing protein processing by massspectrometric identification of sorted N-terminal peptides."; Gevaert K., Goethals M., Martens L., Van Damme J., Staes A.,Thomas G.R., Vandekerckhove J.; Nat. Biotechnol. 21:566-569(2003). Cited for: PROTEIN SEQUENCE OF 2-10, AND ACETYLATION AT ALA-2. | |
Phosphorylation | |
Reference | PubMed |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-72, AND MASSSPECTROMETRY. | |
"A probability-based approach for high-throughput proteinphosphorylation analysis and site localization."; Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.; Nat. Biotechnol. 24:1285-1292(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-72, AND MASSSPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-72, AND MASSSPECTROMETRY. |